Schedule 13D ownership disclosure

ALTAMIRA THERAPEUTICS LTD

Security class unavailable · CUSIP: G0360L134

Event date: 2024-03-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
1.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-24-022034
Form type
SC 13D/A
Filer
Altamira Therapeutics Ltd.
CIK
CIK 1601936
Filed
Mar 13, 2024
Reporting period
Mar 13, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub